Altoida’s NeuroMarker Platform transforms the process with neuroscience-driven tasks that simulate daily activities, capturing motion, speech, and touch data for deeper insights. The self …

Altoida is a pioneer in developing digital biomarkers of neurological disease using augmented reality and machine learning. Our technology platform is designed to enable an objective …

Through a set of tasks that simulate activities of daily living, Altoida’s software medical device for cognitive assessment puts personalized and actionable brain health measurements in the …

Jan 13, 2022 · At Altoida, we use digital biomarkers to radically change the method of assessing brain health and cognitive diseases. After nearly two decades of research, we are developing …

At Altoida, we are revolutionizing the way to assess and measure brain health. Click here to learn more about our mission aimed at helping you achieve better brain health.

Dec 5, 2024 · The research evaluates how the Altoida platform identifies cognitive impairment associated with amyloid deposition and supports the use of digital biomarkers in early …

Dec 19, 2023 · “Altoida's AR cognitive assessment seems to be one of the most promising emerging technologies in this field, and the RADAR-AD study results indicate that Altoida’s …

Oct 15, 2024 · Altoida, a leader in digital neuromarker diagnostics for neurological conditions, announced today the launch of its Scientific Advisory Board (SAB). The newly appointed …

At Altoida, we believe that understanding your brain health should be simple and accessible. For more than two decades, we have partnered with global industry leaders to research and …

The Altoida team is hiring scientists, entrepreneurs, and technologists who want to create a next-generation digital biomarkers platform to revolutionize brain health research and care. We are …